Vertex Names Reshma Kewalramani to Succeed Leiden as CEO, Advance Therapies to 90% of CF Patients
Jeffrey Leiden, who led Vertex's ongoing drive to treat 90% of cystic fibrosis patients, is retiring as CEO; Reshma Kewalramani, now CMO, will succeed him.
0 Comments